CORC  > 中南大学
MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1
Zhou, Bin; Zhu, Honglin; Luo, Hui; Gao, Siming; Dai, Xiaodan; Li, Yisha*; Zuo, Xiaoxia*
刊名Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2017
卷号87期号:Volume 87页码:412-418
关键词Systemic sclerosis Fibrosis miR-202-3p MMP1
ISSN号0753-3322
DOI10.1016/j.biopha.2016.12.080
URL标识查看原文
WOS记录号WOS:000395525600047;PMID:28068631
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3331966
专题中南大学
作者单位1.[Zhou, Bin
2.Gao, Siming
3.Li, Yisha
4.Zuo, Xiaoxia
5.Zhu, Honglin
6.Dai, Xiaodan
7.Luo, Hui] Cent S Univ, Xiangya Hosp, Dept Rheumatol, Changsha 410008, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Zhou, Bin,Zhu, Honglin,Luo, Hui,et al. MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2017,87(Volume 87):412-418.
APA Zhou, Bin.,Zhu, Honglin.,Luo, Hui.,Gao, Siming.,Dai, Xiaodan.,...&Zuo, Xiaoxia*.(2017).MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,87(Volume 87),412-418.
MLA Zhou, Bin,et al."MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 87.Volume 87(2017):412-418.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace